The anti-CD73 antibody significantly reduced the growth of these tumours (Figure 4) and two weeks after the final dose of 10 mg/kg anti-CD73 IgG1, tumour size was reduced to 68% of that seen with tumours treated with a vehicle control. This evidence concerns the gene NT5E and neoplasm.